Lee, H. J., Walter, L. C., Smith, A. K., Shi, Y., Boscardin, J., Cohen, H. J., … Wong, M. L. (2023). Associations of frailty with overall survival (OS) and functional decline among older adults with non-small-cell lung cancer (NSCLC) receiving chemotherapy, immunotherapy, and/ or targeted therapy. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).

Lee, Howard Jinsoo, Louise Christie Walter, Alexander K. Smith, Ying Shi, John Boscardin, Harvey Jay Cohen, Grant Richard Williams, et al. “Associations of frailty with overall survival (OS) and functional decline among older adults with non-small-cell lung cancer (NSCLC) receiving chemotherapy, immunotherapy, and/ or targeted therapy.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.

Lee HJ, Walter LC, Smith AK, Shi Y, Boscardin J, Cohen HJ, et al. Associations of frailty with overall survival (OS) and functional decline among older adults with non-small-cell lung cancer (NSCLC) receiving chemotherapy, immunotherapy, and/ or targeted therapy. In: JOURNAL OF CLINICAL ONCOLOGY. 2023.

Lee, Howard Jinsoo, et al. “Associations of frailty with overall survival (OS) and functional decline among older adults with non-small-cell lung cancer (NSCLC) receiving chemotherapy, immunotherapy, and/ or targeted therapy.” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16, 2023.

Lee HJ, Walter LC, Smith AK, Shi Y, Boscardin J, Cohen HJ, Williams GR, Zeng S, Presley CJ, Magnuson A, Mohile SG, Singhal S, Ursem CJ, Manana AIV, Gubens MA, Blakely CM, Mulvey C, Allen GM, Ostrem J, Wong ML. Associations of frailty with overall survival (OS) and functional decline among older adults with non-small-cell lung cancer (NSCLC) receiving chemotherapy, immunotherapy, and/ or targeted therapy. JOURNAL OF CLINICAL ONCOLOGY. 2023.